文献速递焦虑、强迫与应激相关障碍

曼陀罗重复法个体治疗创伤后应激障碍:一项随机临床试验

Individual Treatment of Posttraumatic Stress Disorder Using Mantram Repetition: A Randomized Clinical Trial.
PubMed 文献 · Am J Psychiatry · 2018-06-20

本研究为两项点、开放分配、盲法评估的随机试验,纳入173名患有军事相关PTSD的退伍军人,比较个体曼陀罗重复疗法与当下中心疗法。结果显示曼陀罗组在CAPS评分改善上显著优于对照组,且在治疗后和2个月随访时均维持优势,失眠减少也更显著。

要点

  • 个体曼陀罗重复疗法在改善PTSD症状严重程度方面优于当下中心疗法。
  • 曼陀罗组在2个月随访时达到PTSD诊断标准缓解的比例显著更高。
  • 曼陀罗组在治疗后和随访时失眠减少均显著优于对照组。

核心结论

  • 在退伍军人PTSD样本中,个体曼陀罗重复疗法在减少PTSD症状严重程度和失眠方面总体上比当下中心疗法更有效。

研究设计与样本

  • 研究为两项点、开放分配、盲法评估的随机试验,纳入173名来自两个退伍军人事务门诊诊所的军事相关PTSD退伍军人(2012年1月至2014年3月)。
  • 曼陀罗组(N=89)学习静默曼陀罗重复、减慢思维和专注一处的技巧;对照组(N=84)接受当下中心疗法,聚焦当前应激事件和问题解决技巧。
  • 两种治疗均以个体形式进行,每周1小时,共8次;主要结局为CAPS评估的PTSD症状严重程度变化,采用意向性分析线性混合模型。

主要发现

  • 曼陀罗组CAPS评分改善显著优于当下中心疗法组,治疗后组间差异为-9.98(95% CI=-3.63, -16.00;d=0.49),2个月随访时组间差异为-9.34(95% CI=-1.50, -17.18;d=0.46)。
  • 曼陀罗组自评PTSD症状严重程度在治疗后低于对照组,但2个月随访时无差异。
  • 完成2个月随访的参与者中,曼陀罗组59%不再符合PTSD诊断标准,显著高于对照组的40%(p<0.04)。
  • 曼陀罗组75%的参与者CAPS评分改善≥10分(临床有意义变化),对照组为61%,两组差异无统计学意义。
  • 曼陀罗组在治疗后和2个月随访时失眠减少均显著大于对照组。

关键数值与推荐

  • 主要结局指标为CAPS评估的PTSD症状严重程度变化。
  • 临床有意义变化定义为CAPS评分改善≥10分。
  • PTSD诊断标准缓解定义为不再符合PTSD诊断标准。

临床怎么用

  • 个体曼陀罗重复疗法可作为退伍军人PTSD的一种非创伤聚焦补充治疗选择,尤其对改善PTSD症状和失眠有效。

局限性

  • 研究为开放分配设计,参与者可能知晓分组,但评估采用盲法。
  • 样本仅来自两个退伍军人事务门诊诊所的军事相关PTSD退伍军人,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Previous studies suggest that group "mantram" (sacred word) repetition therapy, a non-trauma-focused complementary therapy for posttraumatic stress disorder (PTSD), may be an effective treatment for veterans. The authors compared individually delivered mantram repetition therapy and another non-trauma-focused treatment for PTSD. METHOD: The study was a two-site, open-allocation, blinded-assessment randomized trial involving 173 veterans diagnosed with military-related PTSD from two Veterans Affairs outpatient clinics (January 2012 to March 2014). The mantram group (N=89) learned skills for silent mantram repetition, slowing thoughts, and one-pointed attention. The comparison group (N=84) received present-centered therapy, focusing on currently stressful events and problem-solving skills. Both treatments were delivered individually in eight weekly 1-hour sessions. The primary outcome measure was change in PTSD symptom severity, as measured by the Clinician-Administered PTSD Scale (CAPS) and by self-report. Secondary outcome measures included insomnia, depression, anger, spiritual well-being, mindfulness, and quality of life. Intent-to-treat analysis was conducted using linear mixed models. RESULTS: The mantram group had significantly greater improvements in CAPS score than the present-centered therapy group, both at the posttreatment assessment (between-group difference across time, -9.98, 95% CI=-3.63, -16.00; d=0.49) and at the 2-month follow-up (between-group difference, -9.34, 95% CI=-1.50, -17.18; d=0.46). Self-reported PTSD symptom severity was also lower in the mantram group compared with the present-centered therapy group at the posttreatment assessment, but there was no difference at the 2-month follow-up. Significantly more participants in the mantram group (59%) than in the present-centered therapy group (40%) who completed the 2-month follow-up no longer met criteria for PTSD (p<0.04). However, the percentage of participants in the mantram group (75%) compared with participants in the present-centered therapy group (61%) who experienced clinically meaningful changes (≥10-point improvements) in CAPS score did not differ significantly between groups. Reductions in insomnia were significantly greater for participants in the mantram group at both posttreatment assessment and 2-month follow-up. CONCLUSIONS: In a sample of veterans with PTSD, individually delivered mantram repetition therapy was generally more effective than present-centered therapy for reducing PTSD symptom severity and insomnia.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bormann JE, Thorp SR, Smith E, et al. Individual Treatment of Posttraumatic Stress Disorder Using Mantram Repetition: A Randomized Clinical Trial. Am J Psychiatry. 2018. PMID: 29921143. doi:10.1176/appi.ajp.2018.17060611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。